QuiVad

Home / Germany / STADA Arzneimittel Aktiengesellschaft

STADA Arzneimittel Aktiengesellschaft

Short position disclosed on March 30, 2015.

Follow

Evolution of the disclosed total

0%0.2%0.4%0.6%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, asĀ % of capital. Hover or tap the curve to see which funds make it up.
The whole history, peaking at 3.92% on March 2, 2016. The shaded band is the year shown above.

November 1, 2012 today

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
Swiss & Global Asset Management AG0.54%unchangedMarch 30, 2015

Follow by RSS

Get the moves on STADA Arzneimittel Aktiengesellschaft by mail.

No account: one address, one link to confirm, one link to stop in every message.

History of disclosures

140 disclosures on record for this share.
DateFund% of capitalEnd of publication
July 24, 2018Parvus Asset Management Europe Limited0.00%
August 23, 2017Polygon Global Partners LLP0.00%
August 22, 2017Polygon Global Partners LLP0.95%
August 21, 2017Polygon Global Partners LLP0.82%
May 25, 2017Sand Grove Capital Management LLP0.23%
May 16, 2017Sand Grove Capital Management LLP0.00%
May 10, 2017Sand Grove Capital Management LLP0.47%
April 27, 2017Sand Grove Capital Management LLP0.33%
August 1, 2016Marshall Wace LLP0.46%
July 29, 2016Marshall Wace LLP0.50%
July 27, 2016Marshall Wace LLP0.49%
July 19, 2016Marshall Wace LLP0.59%
June 29, 2016Marshall Wace LLP0.69%
June 27, 2016Marshall Wace LLP0.77%
June 16, 2016Marshall Wace LLP0.88%
June 15, 2016Marshall Wace LLP0.90%
June 10, 2016Marshall Wace LLP0.82%
June 8, 2016Marshall Wace LLP0.73%
June 6, 2016Marshall Wace LLP0.68%
June 1, 2016Marshall Wace LLP0.70%
May 31, 2016GAM Investment Management (switzerland) AG0.49%
May 30, 2016GAM Investment Management (switzerland) AG0.55%
May 27, 2016Marshall Wace LLP0.69%
May 27, 2016GAM Investment Management (switzerland) AG0.64%
May 26, 2016Marshall Wace LLP0.59%
May 25, 2016Marshall Wace LLP0.60%
May 18, 2016GAM Investment Management (switzerland) AG0.77%
May 17, 2016Marshall Wace LLP0.77%
May 12, 2016Marshall Wace LLP0.89%
May 10, 2016Marshall Wace LLP0.91%
May 9, 2016Marshall Wace LLP0.89%
May 6, 2016Marshall Wace LLP0.90%
May 5, 2016Marshall Wace LLP0.88%
May 4, 2016Marshall Wace LLP0.90%
May 3, 2016Marshall Wace LLP1.12%
April 26, 2016Marshall Wace LLP1.47%
April 19, 2016Marshall Wace LLP1.59%
April 18, 2016Parvus Asset Management Europe Limited0.60%
March 18, 2016Marshall Wace LLP1.61%
March 15, 2016Marshall Wace LLP1.59%
March 14, 2016Marshall Wace LLP1.61%
March 10, 2016Marshall Wace LLP1.73%
March 7, 2016Marshall Wace LLP1.96%
March 2, 2016Marshall Wace LLP2.00%
March 1, 2016Marshall Wace LLP1.90%
February 25, 2016Marshall Wace LLP1.80%
February 23, 2016Marshall Wace LLP1.74%
February 16, 2016Marshall Wace LLP1.60%
February 12, 2016Marshall Wace LLP1.51%
February 9, 2016Marshall Wace LLP1.40%

Download 140 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in Germany

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, STADA Arzneimittel Aktiengesellschaft, source Bundesanzeiger, data as at March 30, 2015, https://www.quivad.com/action/stada-arzneimittel-aktiengesellschaft